received two red notebooks, it says so
Second Prize of Guangdong Agricultural Technology Promotion Award
Foshan Hi-Tech Progress Award Second Prize
The achievement of this achievement, shows that Wen’s independent innovation ability is continuously enhanced, The comprehensive strength of science and technology continues to improve.
The”Key Technology and Process Research and Development of Veterinary Drug Microencapsulation and Its Industrial Application” project with Wen’s holding subsidiary Zhengdian Biology as the first completed unit won Guangdong The second prize of the Provincial Agricultural Technology Promotion Award and the second prize of the Foshan High-tech Progress Award, and received the award certificate a few days ago.
The project is mainly to break through the key technology of spray condensation microencapsulation granulation, build a common platform for microencapsulation of veterinary drugs, and establish and implement spray condensation microencapsulation. GMP granule/premix production line of veterinary medicine with key technology of granule. Screen suitable surfactants, emulsifiers, thickeners, antioxidants and other materials according to different drug characteristics and different testing requirements of drugs, formulate microencapsulation process formulas for different drugs, and successfully achieve microencapsulation of more than ten products of the company Modification of dosage forms, such as albendazole and ivermectin premix (Chonglihei), Tilmicosin premix (Hulankang), Florfenicol powder (Huyuankang), compound sulfamethoxine Microencapsulated formulas of veterinary chemicals such as pyrimidine premix (five-body rule) and fenbendazole granules (Zhengdian Zhongkang).
The microencapsulation technology has successfully applied for 20 related patents, of which 3 have been authorized. Two new veterinary drugs with microencapsulation technology have been developed:Tilmicosin sustained-release granules and Florfenicol sustained-release granules. Clinical trials are currently underway and new veterinary drugs will be registered. Relying on the technological breakthrough of this project, Zhengdian Biotechnology took the lead in realizing the application of slow-release taste-masking microcapsule technology in veterinary drugs, especially antiparasitic drugs, and carried out industrialized technological transformation of the results to realize the development of microencapsulated technology products. Mass production and sales. The microencapsulated veterinary drug products successfully circumvented many shortcomings of traditional powdered veterinary drugs:such as poor palatability, pungent odor, poor stability, high irritation, difficult storage, inability to slow release and targeted drug delivery, and other shortcomings. More importantly, it can effectively reduce the amount of drugs used and reduce the risk of drug abuse and abuse. It not only saves the cost of medicine for the breeding industry, improves the economic efficiency of breeding, but also reduces the pollution impact of veterinary drugs on the environment, and improves the safety of animal food. Microencapsulated veterinary drugs have been widely recognized by the market since they went on the market.